tiprankstipranks
3 Best Stocks to Buy Now, 6/27/2024, According to Top Analysts
Market News

3 Best Stocks to Buy Now, 6/27/2024, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well. 

Don't Miss our Black Friday Offers:

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio. 

Enovix (NASDAQ:ENVX) –  Enovix develops silicon-anode lithium-ion batteries. Yesterday, Craig-Hallum analyst Anthony Stoss assigned a Buy rating on the stock. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 257%.

JFrog (NASDAQ:FROG) – JFrog provides a software-as-a-service platform. Yesterday, Barclays analyst Ryan MacWilliams initiated a Buy rating on the stock with a price target of $50 per share. Interestingly, 10 out of the 11 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 32%. 

Wave Life Sciences (NASDAQ:WVE) – This is a clinical-stage biotechnology company. Yesterday, Truist Financial analyst Joon Lee reiterated a Buy rating on the stock with a price target of $17 per share. In the last three months, all three Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 235%. 

Who are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure 

Related Articles
TheFlyWave Life Sciences price target raised to $22 from $19 at Mizuho
TipRanks Auto-Generated NewsdeskWave Life Sciences Advances RNA Medicine Innovations
TipRanks Auto-Generated NewsdeskWave Life Sciences’ Q3 2024 Advances in RNA Therapies
Go Ad-Free with Our App